Formex Launches The New Meteor Dial Essence Space Glacier
Essence Space Glacier
Formex
To mark its 25th anniversary, Formex has introduced the new Essence Space Glacier, a limited edition watch that continues the brand's exploration of meteorite dials with a new approach to finishing and detail. Available in both 39 mm and 43 mm sizes, the Space Glacier refines the concept of meteorite in watchmaking, combining high-tech materials, in-house engineering, and COSC-certified precision in a watch that stays true to Formex's ethos of accessible watchmaking.
On wrist
Formex
The dial is made from the Muonionalusta meteorite, believed to be over 4.5 billion years old. Each piece displays a natural Widmanstätten pattern, which is an interlocking crystalline structure formed by millions of years of cooling in deep space. What's new here is the finishing: instead of rhodium, Formex uses 98% pure sterling silver as the base layer, which is then covered by six hand-applied coats of lightly blue-tinted zapon lacquer. The result is a cooler tone with higher contrast and a distinctly icy appearance that brings out the dial's depth without masking the natural texture of the meteorite.
The date window is beveled and machined directly into the solid meteorite, rather than applied to a brass baseplate as is common with most stone dials. It's an interesting technical detail, made possible by the material's conductivity and Formex's in-house manufacturing capabilities. Dial feet are also soldered directly to the meteorite plate, a challenging process given the material's brittleness.
Sellita SW200-1
Formex
The watch is powered by a COSC-certified Sellita SW200-1 automatic movement and housed in the Essence case, known for its Case Suspension System, a set of four spring-mounted supports between the mid-case and case back that help absorb shock. Other features include the brand's quick-release strap system, a micro-adjustable deployant clasp with carbon fiber composite construction, and BGW9 Super-LumiNova on the hands and applied indices for nighttime readability.
Pricing starts at $1,870 USD. Both the 39 mm and 43 mm versions of the Space Glacier are limited to 100 pieces each, with pre-orders opening on April 24, 2025, and deliveries expected by the end of the same month.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time Business News
2 days ago
- Time Business News
Coating Additives – Enhancing Performance, Sustainability, and Innovation
Coating additives are specialized chemical substances used in small quantities to improve the performance and functionality of paints, coatings, and inks. These additives enhance properties such as dispersion, wetting, defoaming, leveling, adhesion, UV resistance, and durability. They play a crucial role in optimizing coating formulations for various surfaces and end-use applications, making them indispensable in industries such as automotive, construction, packaging, and electronics. In recent years, the coating additives sector has experienced significant growth, driven by increasing demand for high-performance, sustainable, and eco-friendly coating solutions. These additives are widely used in decorative and industrial coatings, printing inks, and adhesives. The surge in construction, automotive refinishing, and digital printing applications has contributed to this upward trajectory. Furthermore, the shift toward waterborne and low-VOC formulations continues to open new avenues for innovation and adoption of advanced additives. Evonik Coating Additives: Driving Innovation and Sustainability in 2025 New AERODISP Dispersions for Digital Printing In 2025, Evonik Coating Additives launched four new AERODISP dispersions based on silica (SiO₂) and alumina (Al₂O₃) particles aimed at enhancing waterborne inkjet ink receptive coatings. These dispersions offer excellent dot sharpness and high resolution, critical to the transition from analog to digital printing. By improving ink fixation and spreading behavior on substrates, they elevate the quality of digital prints. This innovation is expected to accelerate the adoption of digital printing technologies, especially in packaging and publishing, boosting demand for performance additives tailored for inkjet formulations. Introduction of Mass Balanced Additives with Reduced Carbon Footprint Evonik introduced TEGO Wet 270 eCO and TEGO Foamex 812 eCO, its first mass-balanced wetting agent and defoamer with a significantly reduced carbon footprint. Produced using ISCC-certified raw materials, these sustainable products deliver the same high-performance standards as their conventional counterparts while supporting global sustainability goals. This move positions Evonik as a leader in green chemistry and is likely to influence more coating manufacturers to adopt carbon-conscious formulations, expanding the market for eco-friendly coating additives. Strategic Partnership with Nippon Paint China Evonik's collaboration with Nippon Paint China marks a strategic milestone aimed at co-developing next-generation coating solutions. This partnership combines Evonik's advanced additive technologies with Nippon's market leadership in Asia. The joint focus on sustainability and performance is expected to yield innovative products that meet evolving regulatory standards and consumer preferences for environmentally responsible coatings. This alliance will likely set new benchmarks in the Asian coating sector, reinforcing Evonik's footprint and elevating competition through innovation. Future Outlook The future of the coating additives industry is poised for robust expansion, fueled by innovation, environmental regulations, and evolving customer demands. With rising investments in R&D and a strong focus on sustainability, the sector is expected to witness the introduction of smarter, multifunctional, and greener additives. Strategic collaborations, like that of Evonik and Nippon Paint, will further shape the global landscape, driving breakthroughs in formulation science and application performance. As digital printing, energy-efficient buildings, and electric vehicles gain traction, the demand for advanced coating additives will continue to surge across regions and industries. About the Author: HTF Market Intelligence is a leading market research company providing end-to-end syndicated and custom market reports, consulting services, and insightful information across the globe. With over 15,000+ reports from 27 industries covering 60+ geographies, value research report, opportunities, and cope with the most critical business challenges, and transform businesses. Analysts at HTF MI focus on comprehending the unique needs of each client to deliver insights that are most suited to their particular requirements. TIME BUSINESS NEWS
Business Wire
27-05-2025
- Business Wire
BeeKeeperAI Enables Icahn School of Medicine at Mount Sinai and Morehouse School of Medicine to Test the Performance of Healthcare AI Models in Their Environments
AUSTIN, Texas--(BUSINESS WIRE)--BeeKeeperAI®, Inc., a pioneer in privacy-enhancing, multi-party collaboration software for AI development and deployment, today announced that Morehouse School of Medicine (MSM) and the Icahn School of Medicine at Mount Sinai will utilize BeeKeeperAI's EscrowAI® platform to rapidly test AI models on their real-world, multi-modal data in chronic heart failure (CHF). This milestone represents the first operational deployment certified under the Coalition for Health AI (CHAI)'s assurance service provider certification process, setting a precedent for how AI models can be responsibly tested and brought to market faster across institutions and populations. 'As we advance our mission to enable responsible, evidence-based AI, this is just the first of many collaborations where CHAI-certified service providers and health institutions will work together to ensure AI serves all patients,' said Dr. Brian Anderson, CEO of CHAI. 'We're proud to see Morehouse School of Medicine, Icahn School of Medicine, and BeeKeeperAI leading the way in developing trusted AI solutions.' MSM, Icahn School of Medicine, and BeeKeeperAI are all members of CHAI and have adopted its scorecard model for algorithm developers seeking to demonstrate real-world performance to the broader market. Their shared goal is to accelerate the responsible development, validation, and market adoption of AI that improves clinical decision-making, reduces hospital readmissions, and ensures needs-based outcomes—particularly for patients with lower resource availability who face disproportionate risk from chronic heart failure. 'To bring healthcare AI to market, speed matters—but so does trust,' said Dr. Michael Blum, MD, Co-founder and CEO of BeeKeeperAI. 'With EscrowAI, Icahn School of Medicine and Morehouse School of Medicine can enable AI developers to securely test their models on high-value, real-world data in days—not months—while preserving patient privacy and model IP. This is how we unlock faster, scalable, and equitable innovation in healthcare.' The curated datasets, based on shared specifications, include clinical, demographic, and social determinants of health data—offering a rare opportunity to assess algorithm performance across institutions serving predominantly resource-limited populations. 'Morehouse School of Medicine is committed to ensuring all patients have the opportunity to achieve optimal outcomes from treatment for chronic heart failure,' said Muhammed Y. Idris, PhD, Assistant Professor, Medicine and Co-Director, Center for the Validation of Digital Health Technologies and Clinical Algorithms at Morehouse School of Medicine. 'By enabling AI developers to securely compute on our data, we're creating the foundation for algorithms that can reduce readmissions and mortality for those most at risk.' 'AI has the potential to transform clinical care delivery, but only if models are proven to be accurate, safe, and effective in real-world and diverse settings,' said Tanvir Kahlon, MD, MBA, Assistant Professor, Advanced Heart Failure and Transplant, Interventional Cardiology at Icahn School of Medicine at Mount Sinai. 'Our work with BeeKeeperAI and Morehouse makes that assurance possible—without compromising privacy or integrity.' Accelerating Trustworthy & Responsible AI with Privacy-Enhancing Technology BeeKeeperAI's EscrowAI platform allows AI model testing inside a data steward's secure environment using Trusted Execution Environments (TEEs) with confidential computing—ensuring data privacy, regulatory compliance, and protection of IP throughout the process. As a recently certified CHAI Assurance Service Provider, BeeKeeperAI meets the highest standards for ethical and secure AI validation. EscrowAI replaces lengthy data access and contracting delays with push-button, compliant testing workflows —compressing timelines and accelerating time-to-value for algorithm developers. Developers can test and prove model performance on real-world, regulated data in a SOC 2-compliant environment aligned with CHAI's data integrity and scorecard framework. The resulting performance reports are immutable, transparent, and reproducible—creating a fast, scalable path to market evaluation and adoption. CHAI Assurance: A Market-Based Model for Responsible AI This collaboration reflects a broader shift in healthcare AI—from evaluations too often based on marketing presentations to more evidence-based, transparent assurance. CHAI's conflict-of-interest and ethics policies ensure independent oversight, while BeeKeeperAI's infrastructure delivers privacy-protected reproducibility, regulatory-grade audit trails, and speed-to-deployment. Together, they support faster validation and value-based procurement for AI solutions that work, including in populations that need them most. As part of this initiative, Icahn School of Medicine and Morehouse School of Medicine will be publishing data catalogs, enabling independent AI testing and validation to support the new benchmark for healthcare AI transparency and efficiency. About BeeKeeperAI BeeKeeperAI is the pioneer in privacy-enhancing technologies, integrating Trusted Execution Environments with confidential computing to accelerate AI validation and deployment in regulated sectors, including healthcare and government. BeeKeeperAI enables real-world data to be used safely and securely, without ever exposing it—empowering institutions to bring trusted AI to market faster. Learn more at Icahn School of Medicine at Mount Sinai is an investor in BeeKeeperAI.
Yahoo
27-05-2025
- Yahoo
United Imaging and HKSH Medical Group Establish Strategic Partnership to Elevate Imaging Excellence
HONG KONG, May 27, 2025 /PRNewswire/ -- United Imaging and HKSH Medical Group announced on Monday the signing of a Memorandum of Understanding (MOU), marking a significant step forward in fostering innovation and shared commitment. The signing ceremony was held during the Asia Summit Global Health, organized by the Hong Kong Trade Development Council (HKTDC), with senior HKTDC officials serving as witnesses. Hong Kong Sanatorium & Hospital, a distinguished institution with a rich legacy of excellence dating back to its founding over a century ago by Dr. Li Shu Fan, the first minister of Ministry of Health of Republic of China, is now equipped with United Imaging's cutting-edge CT technology - the uCT 960+ (CE-certified)/uCT Atlas (FDA-cleared) system featuring 640 slices/16 cm detector coverage. As the first private hospital in Hong Kong, HKSH Medical Group contributes exceptional clinical leadership and deep institutional expertise, informing the optimization of imaging applications. Mr. Wyman LI, Chief Operating Officer of HKSH Medical Group, Director of Hong Kong Sanatorium & Hospital, and Governor of The Li Shu Fan Medical Foundation, remarked,"HKSH is pleased to join hands with United Imaging to promote high quality development in medical imaging. In this collaboration, HKSH will contribute exceptional clinical leadership and deep institutional expertise, informing the optimization of imaging applications, while United Imaging will leverage on its agility and integrated innovation to jointly refine and enhance system capabilities. Through this partnership, we aspire to match and set new benchmarks of excellence in medical imaging internationally." Dr. Jusong Xia, President of International Business at United Imaging, remarked: "We are honored to collaborate with HKSH Medical Group, an institution that shares our commitment to research and clinical excellence. Together, we will accelerate the translation of technological innovation into clinical practice, setting new benchmarks for patient care in Hong Kong and beyond. This is more than an agreement - it's a shared vision for the future of medicine." This collaboration represents a significant milestone. The initial phase of the partnership will prioritize the integration of United Imaging's uCT 960+ with AI technology, providing HKSH Medical Group with advanced diagnostic technologies to enhance early detection and treatment planning. United Imaging remains steadfast in its mission of "Equal Healthcare for All," committed to making advanced healthcare solutions accessible to clinicians and patients worldwide. About United Imaging United Imaging is a global leader in medical imaging technology, dedicated to innovative solutions that enhance clinical outcomes and transform healthcare worldwide. About HKSH Medical Group Officially launched in September 2017, HKSH Medical Group, through its operating members, adopts a multi-faceted, coordinated approach to promote public health and advanced medicine through relentless efforts in clinical excellence, medical training and research as well as public health education. Members of the Group, including Hong Kong Sanatorium & Hospital, HKSH Healthcare, HKSH Eastern Medical Centre and HKSH Cancer Centre, are dedicated to offering top-quality holistic care to patients, upholding the motto 'Quality in Service, Excellence in Care.' Established in 1922, Hong Kong Sanatorium & Hospital is one of the key members of HKSH Medical Group and a leading private hospital in Hong Kong. Living up to its motto of 'Quality in Service, Excellence in Care', the Hospital is committed to serving the public as well as promoting medical education and research. For more information about HKSH Medical Group, please visit View original content: SOURCE United Imaging Healthcare Co., Ltd. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
